Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins

In Vivo

Volumn 27, Issue 2, 2013, Pages 177-187

  De Meirleir, Kenny L ^c   Khaiboullina, Svetlana F ^a   Frémont, Marc ^d   Hulstaert, Jan ^e   Rizvanov, Albert A ^f   Palotás, András ^g   Lombardi, Vincent C ^a,b  

^a Whittemore Peterson Institute   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d R E D LABORATORIES   (Belgium)

^e General Hospital Jan Portaels   (Belgium)

^f KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^g Asklepios Med Bt Private Practice and Research Center   (Hungary)

Author keywords

HERV; Human endogenous retrovirus; ME; Myalgic encephalomyelitis; Pdc; Plasmacytoid dendritic cell

Indexed keywords

CD86 ANTIGEN; GAG PROTEIN; HLA DR ANTIGEN; LECTIN RECEPTOR; LECTIN RECEPTOR C TYPE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENUM; DUODENUM BIOPSY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; NEUROLOGIC DISEASE; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETROVIRUS;

EID: 84876946941     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo- Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall- Gradisbik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML and Stevens S: Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med 270: 327-338, 2011.
2. Choppa PC, Vojdani A, Tagle C, Andrin R and Magtoto L: Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol Cell Probes 12: 301-308, 1998.
3. Klimas NG, Salvato FR, Morgan R and Fletcher MA: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28: 1403-1410, 1990.
4. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, Komaroff AL and Ritz J: Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 139: 3306-3313, 1987.
5. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW and Bleijenberg G: Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38: 383-392, 1994.
6. De Meirleir K, Suhadolnik RJ, Lebleu B and Englebienne P: Antiviral pathway activation in chronic fatigue syndrome and acute infection. Clin Infect Dis 34: 1420-1421; author reply 1421-1422, 2002.
7. Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Muller WE, Schroder HC, Carter WA et al: Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 18(Suppl 1): S96-104, 1994.
8. Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L and Tan EM: Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 98: 1888-1896, 1996.
9. von Mikecz A, Konstantinov K, Buchwald DS, Gerace L and Tan EM: High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 40: 295-305, 1997.
10. Fluge O, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Naess H, Dahl O, Nyland H and Mella O: Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study. PLoS One 6: e26358, 2011.
11. Fluge O and Mella O: Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series. BMC Neurol 9: 28, 2009.
12. Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R et al: A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 116: 103-113, 1992.
13. Compston A and Coles A: Multiple sclerosis. Lancet 372: 1502- 1517, 2008.
14. Utset TO, Fink J and Doninger NA: Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 33: 531-538, 2006.
15. Apperloo-Renkema HZ, Bootsma H, Mulder BI, Kallenberg CG and van der Waaij D: Host-microflora interaction in systemic lupus erythematosus (SLE): colonization resistance of the indigenous bacteria of the intestinal tract. Epidemiol Infect 112: 367-373, 1994.
16. Ebert EC and Hagspiel KD: Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol 45: 436-441.
17. Ghezzi A and Zaffaroni M: Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci 22(Suppl 2): S117-122, 2001.
18. Devanur LD and Kerr JR: Chronic fatigue syndrome. J Clin Virol 37: 139-150, 2006.
19. Maes M, Mihaylova I and Leunis JC: Increased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depression. Neuro Endocrinol Lett 28: 861-867, 2007.
20. Guy-Grand D and Vassalli P: Gut intraepithelial T lymphocytes. Curr Opin Immunol 5: 247-252, 1993.
21. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG and Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371, 2006.
22. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E and Caccavo D: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6: 205-214, 2000.
23. Cooke KR, Olkiewicz K, Erickson N and Ferrara JL: the role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 8: 441-448, 2002.
24. Lee PI, Ciccone EJ, Read SW, Asher A, Pitts R, Douek DC, Brenchley JM and Sereti I: Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia. J Infect Dis 199: 1664-1670, 2009.
25. Lee YK, Menezes JS, Umesaki Y and Mazmanian SK: Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108(Suppl 1): 4615-4622.
26. Balada E, Vilardell-Tarres M and Ordi-Ros J: Implication of human endogenous retroviruses in the development of autoimmune diseases. Int Rev Immunol 29: 351-370.
27. Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A and Tristem M: Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J Virol 79: 12507-12514, 2005.
28. Weiss RA: the discovery of endogenous retroviruses. Retrovirology 3: 67, 2006.
29. Lefebvre S, Hubert B, Tekaia F, Brahic M and Bureau JF: Isolation from human brain of six previously unreported cDNAs related to the reverse transcriptase of human endogenous retroviruses. AIDS Res Hum Retroviruses 11: 231-237, 1995.
30. Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D and Sturfelt G: Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus. Correlation with autoantibodies and clinical manifestations. Arthritis Rheum 37: 57-66, 1994.
31. Bengtsson A, Blomberg J, Nived O, Pipkorn R, Toth L and Sturfelt G: Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly (amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum 39: 1654-1663, 1996.
32. Rasmussen HB, Geny C, Deforges L, Perron H, Tourtelotte W, Heltberg A and Clausen J: Expression of endogenous retroviruses in blood mononuclear cells and brain tissue from multiple sclerosis patients. Acta Neurol Scand Suppl 169: 38-44, 1997.
33. Query CC and Keene JD: A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 51: 211-220, 1987.
34. Sutkowski N, Conrad B, Thorley-Lawson DA and Huber BT: Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15: 579-589, 2001.
35. Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN and Lafon M: Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 287: 321-332, 2001.
36. Carruthers B, Jain AK, De Meirleir K, Peterson D, Klimas N, Lerner A, Bested A, Flor-Henry P, Joshi P, Powles A, Sherkey J and van de Sande M: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols. J Chronic Fatigue Syndrome 11: 1-12, 2003.
37. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG and Komaroff A: the chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121: 953-959, 1994.
38. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW and Schmitz J: BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165: 6037-6046, 2000.
39. Dzionek A, Inagaki Y, Okawa K, Nagafune J, Rock J, Sohma Y, Winkels G, Zysk M, Yamaguchi Y and Schmitz J: Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. Hum Immunol 63: 1133-1148, 2002.
40. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Gunther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y and Schmitz J: BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194: 1823-1834, 2001.
41. Chehimi J, Starr SE, Kawashima H, Miller DS, Trinchieri G, Perussia B and Bandyopadhyay S: Dendritic cells and IFNalpha- producing cells are two functionally distinct non-B, nonmonocytic HLA-DR+ cell subsets in human peripheral blood. Immunology 68: 486-490, 1989.
42. Laupeze B, Fardel O, Onno M, Bertho N, Drenou B, Fauchet R and Amiot L: Differential expression of major histocompatibility complex class Ia, Ib, and II molecules on monocytes-derived dendritic and macrophagic cells. Hum Immunol 60: 591-597, 1999.
43. Lee K, Ruscetti F, Lloyd P, Rein A, Fanning-Heidecke G and KewalRamani V: Development of a GFP-indicator Cell Line for the Detection of XMRV. Abstracts Presented at the 18th Conference on Retroviruses and Opportunistic Infections Paper # 2152011.
44. Lombardi VC, Hagen KS, Hunter KW, Diamond JW, Smith- Gagen J, Yang W and Mikovits JA: Xenotropic murine leukemia virus-related virus-associated chronic fatigue syndrome reveals a distinct inflammatory signature. In Vivo 25: 307-314.
45. Piqueras B, Connolly J, Freitas H, Palucka AK and Banchereau J: Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107: 2613-2618, 2006.
46. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S and Liu YJ: the nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837, 1999.
47. Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL and Barrat FJ: Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J Exp Med 203: 1999-2008, 2006.
48. Baumgart DC, Metzke D, Guckelberger O, Pascher A, Grotzinger C, Przesdzing I, Dorffel Y, Schmitz J and Thomas S: Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis. Clin Exp Immunol 166: 46-54.
49. Trinchieri G, Santoli D, Dee RR and Knowles BB: Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med 147: 1299-1313, 1978.
50. Lodoen MB and Lanier LL: Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391-398, 2006.
51. Whiteside TL and Friberg D: Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 105: 27S-34S, 1998.
52. Natelson BH, Weaver SA, Tseng CL and Ottenweller JE: Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol 12: 52-55, 2005.
53. Vernon SD, Unger ER, Dimulescu IM, Rajeevan M and Reeves WC: Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 18: 193-199, 2002.
54. Chao CC, Gallagher M, Phair J and Peterson PK: Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis 162: 1412-1413, 1990.
55. Olive C, Gatenby PA and Serjeantson SW: Persistence of gamma/delta T cell oligoclonality in the peripheral blood of rheumatoid arthritis patients. Immunol Cell Biol 72: 7-11, 1994.
56. Bieganowski P, Bieganowska K, Zaborski J and Czlonkowska A: Oligoclonal expansion of gamma delta T cells in cerebrospinal fluid of multiple sclerosis patients. Mult Scler 2: 78-82, 1996.
57. Sim GK and Augustin A: the presence of an endogenous murine leukemia virus sequence correlates with the peripheral expansion of gamma delta T cells bearing the BALB invariant delta (BID) T cell receptor delta. J Exp Med 178: 1819-1824, 1993.
58. Stoye JP: Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol 10: 395-406, 2012.
59. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK and Johanning GL: Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res 68: 5869-5877, 2008.
60. Ariza ME and Williams MV: A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis? J Invest Dermatol 131: 2419-2427.
61. Tai AK, Luka J, Ablashi D and Huber BT: HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 46: 47-48, 2009.
62. Fremont M, Metzger K, Rady H, Hulstaert J and De Meirleir K: Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. In Vivo 23: 209-213, 2009.
63. Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H and Marche PN: the envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 176: 7636-7644, 2006.
64. Kelleher CA, Wilkinson DA, Freeman JD, Mager DL and Gelfand EW: Expression of novel-transposon-containing mRNAs in human T cells. J Gen Virol 77(Pt 5): 1101-1110, 1996.
65. Hokama Y, Empey-Campora C, Hara C, Higa N, Siu N, Lau R, Kuribayashi T and Yabusaki K: Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. J Clin Lab Anal 22: 99-105, 2008.
66. Klein R and Berg PA: High incidence of antibodies to 5- hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res 1: 21-26, 1995.
67. Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi KI, Takano T, Kanakura Y and Amino N: Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med 12: 225-230, 2003.
68. Vernon SD and Reeves WC: Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis 2: 5, 2005.
69. Wheatland R: Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitaryadrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression. Med Hypotheses 65: 287-295, 2005.